X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18) 18
index medicus (14) 14
female (12) 12
male (12) 12
adult (11) 11
hematology (10) 10
middle aged (10) 10
aged (9) 9
treatment outcome (8) 8
oncology (7) 7
young adult (7) 7
cancer (6) 6
chronic lymphocytic leukemia (6) 6
cyclophosphamide (6) 6
fludarabine (6) 6
leukemia (6) 6
retrospective studies (6) 6
rituximab (6) 6
survival (6) 6
analysis (5) 5
chemotherapy (5) 5
cll (5) 5
prognosis (5) 5
aged, 80 and over (4) 4
chronic lymphatic leukemia (4) 4
diagnosis (4) 4
hematopoietic stem cell transplantation (4) 4
immunotherapy (4) 4
lymphatic leukemia (4) 4
neutropenia (4) 4
transplantation, homologous (4) 4
antimitotic agents (3) 3
antineoplastic agents (3) 3
antineoplastic agents - adverse effects (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
bone marrow (3) 3
care and treatment (3) 3
child (3) 3
cladribine (3) 3
clinical trials (3) 3
experience (3) 3
hairy cell leukemia (3) 3
health aspects (3) 3
leukemia, lymphocytic, chronic, b-cell - drug therapy (3) 3
leukemia, lymphocytic, chronic, b-cell - mortality (3) 3
leukemia, myelogenous, chronic, bcr-abl positive - therapy (3) 3
lymphoma (3) 3
open-label (3) 3
patients (3) 3
proportional hazards models (3) 3
risk factors (3) 3
stem cells (3) 3
survival analysis (3) 3
therapy (3) 3
transplantation (3) 3
abridged index medicus (2) 2
administration, oral (2) 2
adolescent (2) 2
aerospace medicine (2) 2
age (2) 2
anthracycline toxicity (2) 2
antibodies, monoclonal, murine-derived - administration & dosage (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
bendamustine (2) 2
bone-marrow-transplantation (2) 2
chemoimmunotherapy (2) 2
childhood malignancy (2) 2
children (2) 2
chlorambucil (2) 2
cyclophosphamide - administration & dosage (2) 2
epidemiology (2) 2
fcr (2) 2
follow-up studies (2) 2
graft vs host disease - prevention & control (2) 2
guidelines (2) 2
hcl (2) 2
hemic and lymphatic diseases (2) 2
immunosuppressive agents - therapeutic use (2) 2
initial therapy (2) 2
kaplan-meier estimate (2) 2
leukemia, lymphocytic, chronic, b-cell - diagnosis (2) 2
leukemia, lymphocytic, chronic, b-cell - pathology (2) 2
lymphocytic leukemia (2) 2
medical research (2) 2
medicine, general & internal (2) 2
minimal residual disease (2) 2
multicenter (2) 2
obinutuzumab (2) 2
patient outcomes (2) 2
pentostatin (2) 2
phase-3 (2) 2
pilots (2) 2
previously untreated patients (2) 2
pyrimidines - adverse effects (2) 2
research (2) 2
risk (2) 2
safety (2) 2
second malignancy (2) 2
seizures in pilots (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 3999 - 3999
Abstract Introduction: Failure to achieve remission following standard induction is a poor prognostic sign in patients with acute myeloid leukemia (AML).... 
Journal Article
European Journal of Haematology, ISSN 0902-4441, 09/2018, Volume 101, Issue 3, pp. 399 - 406
Journal Article
Journal Article
Rambam Maimonides medical journal, ISSN 2076-9172, 10/2014, Volume 5, Issue 4, p. e0027
Achievement of complete response (CR) to therapy in chronic lymphocytic leukemia (CLL) has become a feasible goal, directly correlating with prolonged... 
ASO-PCR | flow cytometry | minimal residual disease | chronic lymphocytic leukemia | prognosis | survival
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Suppl_1, pp. 5566 - 5566
Abstract Chronic lymphocytic leukemia (CLL) is a disease of elderly patients. Despite the development of novel agents and new monoclonal antibodies, FCR still... 
Journal Article
American Journal of Hematology, ISSN 0361-8609, 11/2014, Volume 89, Issue 11, pp. E218 - E222
Journal Article
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 07/2019, Volume 60, Issue 8, pp. 2079 - 2081
Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 21, pp. 4574 - 4574
Abstract Abstract 4574 Leukocytosis has been documented as a risk factor for thrombotic events in various clinical conditions such as ischemic heart diseases,... 
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 08/2019, Volume 60, Issue 10, pp. 2449 - 2456
Autologous stem cell transplantation (ASCT), intensifying anti-leukemic effects without significant treatment-related mortality (TRM), is particularly... 
core-binding factor (CBF) translocation | autologous SCT (ASCT) | NPM1 mutation | Acute myeloid leukemia (AML)
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 3935 - 3935
Abstract Introduction: Acute graft-versus-host disease (aGVHD) is a major limitation of allogeneic stem cell transplantation (alloSCT) due to associated... 
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 1553 - 1553
Abstract Background: The ability to express the ABH antigens in oral mucosa and saliva is present in about 80% of the general population (hence called... 
Journal Article
Anticancer Research, ISSN 0250-7005, 11/2018, Volume 38, Issue 11, p. 6423
Background/Aim: In this retrospective study, we summarized the national Israeli experience with hairy cell leukemia (HCL) in a large cohort of patients with a... 
Schedules | Intravenous administration | Leukemia | Medical services | Data processing | Males | Minority & ethnic groups | Patients | Survival | Medical centres | Demographics | Hairy cell leukemia | Cladribine | Age
Journal Article
Leukemia Research, ISSN 0145-2126, 07/2019, Volume 82, pp. 24 - 28
Major advances in the treatment of patients with hairy cell leukemia (HCL) have been made following the introduction of purine analogues. The major significant... 
HCL | Hairy cell leukemia | Nadir | Neutropenic fever | G-CSF | Neutropenia
Journal Article
Leukemia research, ISSN 0145-2126, 07/2019, Volume 82, p. 24
Major advances in the treatment of patients with hairy cell leukemia (HCL) have been made following the introduction of purine analogues. The major significant... 
Antimitotic agents | Granulocyte colony-stimulating factor | Antineoplastic agents | Leukemia, Hairy cell | Neutropenia
Journal Article
Journal Article
Anticancer Research, ISSN 0250-7005, 05/2015, Volume 35, Issue 5, pp. 2861 - 2866
Background/ Aim: The prognostic significance of hyperleukocytosis in chronic lymphocytic leukemia (CLL) remains uncertain. The aim of the present study was to... 
Journal Article
Harefuah, ISSN 0017-7768, 09/2017, Volume 156, Issue 9, p. 589
Stem cell transplantation is indicated in hematological malignancies as well as some solid tumors and congenital abnormalities. Autologous transplantation... 
Europe | Humans | Hematopoietic Stem Cell Transplantation | Graft vs Host Disease - prevention & control | Transplantation Conditioning | Transplantation, Homologous
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.